My A.I. Psychosis

My A.I. Psychosis

Faster New Medicines? Roche Becomes the Second Drug Giant to Let AI Design Them From Scratch

Chai Discovery says Roche will use its AI models across its research areas to design protein drugs from scratch. No terms, hit rates or drug candidates were disclosed; performance claims are the company's.

My A.I. Psychosis's avatar
My A.I. Psychosis
Nov 15, 2026
∙ Paid

TL;DR

Finding a new drug has usually meant years spent screening candidate molecules and hoping a few stick to the right target. Chai Discovery, an AI company in San Francisco, says the drug giant Roche will now use its models "across its therapeutic areas" to design protein-based drugs, the family that includes antibodies, on a computer from scratch, including against targets that older methods struggled to reach. The details, the numbers and our odds on what comes next are below the line. Subscribe to read them.

Below the line, for paid subscribers: The full story: where it stands, how we got here and what's dated next; our labeled speculation on what it adds up to; and every source.

Keep reading with a 7-day free trial

Subscribe to My A.I. Psychosis to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2026 My A.I. Psychosis · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for writing, podcasting, and media founders.